AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-84
Results: 1-25/84

Authors: SCHMIT JC MARTINEZPICADO J RUIZ L TURAL C VANLAETHEM K CABRERA C IBANEZ A PUIG T WITVROUW M DESMYTER J DECLERCQ E CLOTET B VANDAMME AM
Citation: Jc. Schmit et al., EVOLUTION OF HIV DRUG-RESISTANCE IN ZIDOVUDINE ZALCITABINE-EXPERIENCED AND ZIDOVUDINE/DIDANOSINE-EXPERIENCED PATIENTS RECEIVING LAMIVUDINE-CONTAINING COMBINATION THERAPY/, Antiviral therapy, 3(2), 1998, pp. 81-88

Authors: WITVROUW M DAELEMANS D PANNECOUQUE C NEYTS J ANDREI G SNOECK R VANDAMME AM BALZARINI J DESMYTER J BABA M DECLERCQ E
Citation: M. Witvrouw et al., BROAD-SPECTRUM ANTIVIRAL ACTIVITY AND MECHANISM OF ANTIVIRAL ACTION OF THE FLUOROQUINOLONE DERIVATIVE K-12, Antiviral chemistry & chemotherapy, 9(5), 1998, pp. 403-411

Authors: DEBYSER Z VANWIJNGAERDEN E VANLAETHEM K BEUSELINCK K REYNDERS M DECLERCQ E DESMYTER J VANDAMME AM
Citation: Z. Debyser et al., FAILURE TO QUANTIFY VIRAL LOAD WITH 2 OF THE 3 COMMERCIAL METHODS IN A PREGNANT WOMAN HARBORING AN HIV TYPE-1 SUBTYPE-G STRAIN, AIDS research and human retroviruses, 14(5), 1998, pp. 453-459

Authors: SHENG L SOUMILLION A PEERLINCK K VERSLYPE C SCHELSTRAETE R GYSELINCK F EMONDS MP HESS G VERMYLEN J DESMYTER J YAP SH
Citation: L. Sheng et al., ANTI-HEPATITIS-G E2 ANTIBODY DETECTION AND ITS RELATION TO SERUM HGV-RNA IN PATIENTS WITH CLOTTING DISORDERS - HIGH PREVALENCE OF HGV INFECTION AND SPONTANEOUS REMISSION, Thrombosis and haemostasis, 79(4), 1998, pp. 752-755

Authors: SCHMIT JC VANLAETHEM K RUIZ L HERMANS P SPRECHER S SONNERBORG A LEAL M HARRER T CLOTET B ARENDT V LISSEN E WITVROUW M DESMYTER J DECLERCQ E VANDAMME AM
Citation: Jc. Schmit et al., MULTIPLE DIDEOXYNUCLEOSIDE ANALOG-RESISTANT (MDDNR) HIV-1 STRAINS ISOLATED FROM PATIENTS FROM DIFFERENT EUROPEAN COUNTRIES, AIDS, 12(15), 1998, pp. 2007-2015

Authors: HOPPENBROUWERS K LAGOS R SWENNEN B ETHEVENAUX C KNOPS J LEVINE MM DESMYTER J
Citation: K. Hoppenbrouwers et al., SAFETY AND IMMUNOGENICITY OF AN HAEMOPHILUS-INFLUENZAE TYPE B-TETANUSTOXOID CONJUGATE (PRP-T) AND DIPHTHERIA-TETANUS-PERTUSSIS (DTP) COMBINATION VACCINE ADMINISTERED IN A DUAL-CHAMBER SYRINGE TO INFANTS IN BELGIUM AND CHILE, Vaccine, 16(9-10), 1998, pp. 921-927

Authors: SCHMIT JC RUIZ L STUYVER L VANLAETHEM K VANDERLINDEN I PUIG T ROSSAU R DESMYTER J DECLERCQ E CLOTET B VANDAMME AM
Citation: Jc. Schmit et al., COMPARISON OF THE LIPA HIV-1 RT TEST, SELECTIVE PCR AND DIRECT SOLID-PHASE SEQUENCING FOR THE DETECTION OF HIV-1 DRUG-RESISTANCE MUTATIONS, Journal of virological methods, 73(1), 1998, pp. 77-82

Authors: VANLAETHEM K BEUSELINCK K VANDOOREN S DECLERCQ E DESMYTER J VANDAMME AM
Citation: K. Vanlaethem et al., DIAGNOSIS OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION BY A POLYMERASE-CHAIN-REACTION ASSAY EVALUATED IN PATIENTS HARBORING STRAINS OF DIVERSEGEOGRAPHICAL ORIGIN, Journal of virological methods, 70(2), 1998, pp. 153-166

Authors: VANRANST M DESMYTER J
Citation: M. Vanranst et J. Desmyter, POSTEXPOSURE PROPHYLAXIS AFTER ACCIDENTAL PRION INOCULATION, Lancet, 351(9102), 1998, pp. 600-600

Authors: WITVROUW M ARRANZ ME PANNECOUQUE C DECLERCQ R JONCKHEERE H SCHMIT JC VANDAMME AM DIAZ JA INGATE ST DESMYTER J ESNOUF R VANMEERVELT L VEGA S BALZARINI J DECLERCQ E
Citation: M. Witvrouw et al., 1,1,3-TRIOXO-2H,4H-THIENO[3,4-E][1,2,4]THIADIAZINE (TTD) DERIVATIVES - A NEW CLASS OF NONNUCLEOSIDE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) REVERSE-TRANSCRIPTASE INHIBITORS WITH ANTI-HIV-1 ACTIVITY, Antimicrobial agents and chemotherapy, 42(3), 1998, pp. 618-623

Authors: SALEMI M VANDOOREN S AUDENAERT E DELAPORTE E GOUBAU P DESMYTER J VANDAMME AM
Citation: M. Salemi et al., 2 NEW HUMAN T-LYMPHOTROPIC VIRUS TYPE-I PHYLOGENETIC SUBTYPES IN SEROINDETERMINATES, A MBUTI PYGMY AND A GABONESE, HAVE CLOSEST RELATIVES AMONG AFRICAN STLV-I STRAINS, Virology (New York, N.Y. Print), 246(2), 1998, pp. 277-287

Authors: VANBRUSSEL M SALEMI M LIU HF GABRIELS J GOUBAU P DESMYTER J VANDAMME AM
Citation: M. Vanbrussel et al., THE SIMIAN T-LYMPHOTROPIC VIRUS STLV-PP1664 FROM PAN-PANISCUS IS DISTINCTLY RELATED TO HTLV-2 BUT DIFFERS IN GENOMIC ORGANIZATION, Virology, 243(2), 1998, pp. 366-379

Authors: DONDERS GGG DESMYTER J VEREECKEN A
Citation: Ggg. Donders et al., VAGINITIS, The New England journal of medicine, 338(21), 1998, pp. 1548-1548

Authors: ESTE JA CABRERA C SCHOLS D CHEREPANOV P GUTIERREZ A WITVROUW M PANNECOUQUE C DEBYSER Z RANDO RF CLOTET B DESMYTER J DECLERCQ E
Citation: Ja. Este et al., HUMAN-IMMUNODEFICIENCY-VIRUS GLYCOPROTEIN GP120 AS THE PRIMARY TARGETFOR THE ANTIVIRAL ACTION OF AR177 (ZINTEVIR), Molecular pharmacology, 53(2), 1998, pp. 340-345

Authors: VANDAMME AM SALEMI M VANBRUSSEL M LIU HF VANLAETHEM K VANRANST M MICHELS L DESMYTER J GOUBAU P
Citation: Am. Vandamme et al., AFRICAN ORIGIN OF HUMAN T-LYMPHOTROPIC VIRUS TYPE-2 (HTLV-2) SUPPORTED BY A POTENTIAL NEW HTLV-2D SUBTYPE IN CONGOLESE BAMBUTI EFE PYGMIES, Journal of virology, 72(5), 1998, pp. 4327-4340

Authors: SALEMI M VANDAMME AM GRADOZZI C VANLAETHEM K CATTANEO E TAYLOR G CASOLI C GOUBAU P DESMYTER J BERTAZZONI U
Citation: M. Salemi et al., EVOLUTIONARY RATE AND GENETIC-HETEROGENEITY OF HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-II (HTLV-II) USING ISOLATES FROM EUROPEAN INJECTING DRUG-USERS, Journal of molecular evolution, 46(5), 1998, pp. 602-611

Authors: VANDOOREN S GOTUZZO E SALEMI M WATTS D AUDENAERT E DUWE S ELLERBROK H GRASSMANN R HAGELBERG E DESMYTER J VANDAMME AM
Citation: S. Vandooren et al., EVIDENCE FOR A POST-COLUMBIAN INTRODUCTION OF HUMAN T-CELL LYMPHOTROPIC VIRUS IN LATIN-AMERICA, Journal of General Virology, 79, 1998, pp. 2695-2708

Authors: DEBYSER Z REYNDERS M GOUBAU P DESMYTER J
Citation: Z. Debyser et al., COMPARATIVE-EVALUATION OF 3 ELISA TECHNIQUES AND AN INDIRECT IMMUNOFLUORESCENCE ASSAY FOR THE SEROLOGICAL DIAGNOSIS OF EPSTEIN-BARR-VIRUS INFECTION, Clinical and diagnostic virology, 8(1), 1997, pp. 71-81

Authors: WITVROUW M SCHMIT JC VANREMOORTEL B DAELEMANS D ESTE JA VANDAMME AM DESMYTER J DECLERCQ E
Citation: M. Witvrouw et al., CELL TYPE-DEPENDENT EFFECT OF SODIUM VALPROATE ON HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION IN-VITRO, AIDS research and human retroviruses, 13(2), 1997, pp. 187-192

Authors: LIU HF GOUBAU P VANBRUSSEL M DESMYTER J VANDAMME AM
Citation: Hf. Liu et al., PHYLOGENETIC ANALYSIS OF A SIMIAN T-LYMPHOTROPIC VIRUS TYPE-I FROM A HAMADRYAS BABOON, AIDS research and human retroviruses, 13(17), 1997, pp. 1545-1548

Authors: BEUTELS M VANDAMME P AELVOET W DESMYTER J DONDEYNE F GOILAV C MAK R MUYLLE L PIERARD D STROOBANT A VANLOOCK F WAUMANS P VRANCKX R
Citation: M. Beutels et al., PREVALENCE OF HEPATITIS-A, HEPATITIS-B AND HEPATITIS-C IN THE FLEMISHPOPULATION, European journal of epidemiology, 13(3), 1997, pp. 275-280

Authors: SHENG L SOUMILLION A PEERLINCK K VERSLYPE C VANPELT J SCHELSTRAETE R EMONDS MP HESS G DESMYTER J VERMYLEN J YAP SH
Citation: L. Sheng et al., DETECTION OF HGV-RNA IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS (PBMC) ANDIN SERUM OF ANTI-HGV-E2 POSITIVE HEMOPHILIACS, Hepatology, 26(4), 1997, pp. 784-784

Authors: DONDERS GGG DESMYTER J HOOFT P DEWET GH
Citation: Ggg. Donders et al., APPARENT FAILURE OF ONE INJECTION OF BENZATHINE PENICILLIN-G SYPHILISDURING PREGNANCY IN HUMAN IMMUNODEFICIENCY VIRUS-SERONEGATIVE AFRICANWOMEN, Sexually transmitted diseases, 24(2), 1997, pp. 94-101

Authors: VANDAMME AM VANLAETHEM K LIU HF VANBRUSSEL M DELAPORTE E COSTA CMDC FLEISCHER C TAYLOR G BERTAZZONI U DESMYTER J GOUBAU P
Citation: Am. Vandamme et al., USE OF A GENERIC POLYMERASE CHAIN-REACTION ASSAY DETECTING HUMAN T-LYMPHOTROPIC VIRUS (HTLV) TYPE-I, TYPE-II AND DIVERGENT SIMIAN STRAINS IN THE EVALUATION OF INDIVIDUALS WITH INDETERMINATE HTLV SEROLOGY, Journal of medical virology, 52(1), 1997, pp. 1-7

Authors: WITVROUW M BALZARINI J PANNECOUQUE C JHAUMEERLAULLOO S ESTE JA SCHOLS D CHEREPANOV P SCHMIT JC DEBYSER Z VANDAMME AM DESMYTER J RAMADAS SR DECLERCQ E
Citation: M. Witvrouw et al., SRR-SB3, A DISULFIDE-CONTAINING MACROLIDE THAT INHIBITS A LATE-STAGE OF THE REPLICATIVE CYCLE OF HUMAN-IMMUNODEFICIENCY-VIRUS, Antimicrobial agents and chemotherapy, 41(2), 1997, pp. 262-268
Risultati: 1-25 | 26-50 | 51-75 | 76-84